Shreelaxmi Gavas
Molecular Biology · 2021
A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 26 citations into it
- Biomaterials — 20 citations into it
- Biomedical Engineering — 19 citations into it
- Cancer Research — 7 citations into it
Whom Shreelaxmi Gavas trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- G. Raposo
- M. Dobrovolskaia
- N. Kamaly
- W. Stoorvogel
- Vladimir Torchilin
- Mauro Ferrari
- Nicholas J. Schork
- Sameer Quazi
- Theresa M. Allen
- M. Üner
Who trusts Shreelaxmi Gavas overall
Papers from Shreelaxmi Gavas's perspective
Ordered by how strongly the researchers Shreelaxmi Gavas trusts endorse each paper. Same corpus, a different order for every researcher.
- A combinatorial library of lipid-like materials for delivery of RNAi therapeutics (Nature Biotechnology)
- Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles (Cellular and Molecular Life Sciences)
- Active targeting schemes for nanoparticle systems in cancer therapeutics. (Advanced Drug Delivery Reviews)
- Pathology: Cancer cells compress intratumour vessels (Nature)
- Extracellular vesicles: Exosomes, microvesicles, and friends (Journal of Cell Biology)
- Tumor delivery of macromolecular drugs based on the EPR effect. (Advanced Drug Delivery Reviews)
- Nanoparticle-mediated cellular response is size-dependent. (Nature Nanotechnology)
- Treating metastatic cancer with nanotechnology (Nature Reviews. Cancer)
- Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. (Cancer Research)
- Cancer nanotechnology: opportunities and challenges (Nature Reviews. Cancer)
Their papers
- Nanoparticles for Cancer Therapy: Current Progress and Challenges (2021) — 805 citations